Reduced backlog of pending approval processes for pharmaceutical companies in Mexico
in MexicoTrade barrier summary
Due to UK government intervention, delays in approval processes with Mexican health regulators are being addressed. This means that UK businesses should be able to enter the market without undue delay.
Sectors affected
- Pharmaceuticals and biotechnology
- Medical devices and equipment
- Healthcare services
Resolved
Yes - February 2025
Date reported
28 April 2021
Last updated
18 February 2026
Public ID
PID-BQO63G
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.